What are the recommended acute and preventive migraine treatment options for pediatric patients, including weight‑based dosing and age‑specific guidelines?

Migraine Treatment in Pediatric Patients

Acute Treatment

For children and adolescents with migraine, ibuprofen is the first-line acute treatment across all ages, while adolescents (≥12 years) should receive triptans—particularly intranasal formulations or combination therapy with NSAIDs—for moderate to severe attacks. 1

First-Line Acute Therapy

• Ibuprofen is effective for acute migraine treatment in all pediatric patients (children >6 years and adolescents) and should be used as initial therapy 1, 2
• Acetaminophen is probably effective and represents an alternative first-line option, though evidence is slightly weaker than for ibuprofen 3, 2
• Counsel families to treat attacks early in the migraine episode for optimal efficacy 1

Triptan Therapy for Adolescents

For adolescents ≥12 years with moderate to severe migraine:

• Sumatriptan/naproxen combination (oral) has high-confidence evidence for efficacy and should be strongly considered 1, 2
• Zolmitriptan nasal spray has high-confidence evidence for achieving headache freedom at 2 hours 1, 2
• Sumatriptan nasal spray is FDA-approved and effective for adolescents 1, 4, 3
• Rizatriptan ODT (orally disintegrating tablet) is FDA-approved for children ≥6 years and adolescents, though evidence quality is mixed 1, 4
• Almotriptan oral can be considered as an alternative triptan option 1

Tailoring Acute Treatment

• If one triptan fails, trial a different triptan or switch to an NSAID-triptan combination, as response varies between agents 1
• For rapidly escalating pain, use non-oral triptan formulations (nasal spray) rather than oral tablets 1
• For prominent nausea/vomiting, prescribe non-oral triptans or add an anti-emetic medication to the regimen 1

Critical Counseling Points

• Educate families about medication overuse headache and the importance of limiting acute medication use to avoid transformation to chronic daily headache 1
• Discuss lifestyle factors including adequate sleep, regular exercise, hydration, caffeine avoidance, and not skipping meals 1, 4
• Identify and counsel on individual migraine triggers 1

Preventive Treatment

Preventive therapy should be considered for children and adolescents with frequent (typically ≥4 per month) or disabling migraines, or those developing medication overuse, but families must understand that placebo response rates approach 60% in pediatric trials. 1

Critical Discussion Before Starting Prevention

• Transparently discuss with patients and families that placebo was as effective as active medication in many pediatric preventive trials, with approximately 60% of patients improving with lifestyle management and optimized acute therapy alone 1, 4
• This high placebo response means the decision to use preventive medication should be shared between clinician and family, weighing potential side effects against modest additional benefit 1

Evidence-Based Preventive Options

The following agents have some evidence supporting their use, though quality varies:

• Amitriptyline combined with cognitive behavioral therapy (CBT) has evidence for efficacy and should be discussed as a preventive option 1
• Topiramate has evidence supporting use but carries teratogenic risk; mandatory counseling about effective contraception and folate supplementation is required for adolescent females (Grade A recommendation) 1
• Propranolol has evidence supporting consideration for prevention 1

Agents with Insufficient or Negative Evidence

• Divalproex/valproate has insufficient evidence in pediatrics and carries significant teratogenic risk requiring the same contraception/folate counseling as topiramate 1
• OnabotulinumtoxinA has insufficient evidence in the pediatric population 1
• Amitriptyline alone (without CBT) has insufficient evidence 1
• Nimodipine has insufficient evidence 1

Practical Preventive Approach

The most effective preventive strategy combines three elements:

1. Lifestyle management: Sleep hygiene, regular exercise, adequate hydration, caffeine limitation, avoiding meal skipping 4
2. Optimally dosed acute therapy: Ensuring adequate doses of ibuprofen or triptans are used early in attacks 4
3. Pharmacologic prevention: Only when the above measures plus a preventive medication with some evidence for efficacy are needed 4

Common Pitfalls to Avoid

• Undertreating acute attacks by using subtherapeutic doses of NSAIDs or delaying triptan use until pain is severe 1, 2
• Starting preventive medication without first optimizing acute treatment and lifestyle factors 4
• Failing to counsel about teratogenicity when prescribing topiramate or valproate to adolescent females of childbearing potential 1
• Not educating about medication overuse leading to transformation to chronic daily headache 1
• Abandoning all triptans after one fails, rather than trying alternative triptan formulations or agents 1

Age-Specific Considerations

• Children <12 years: Limit acute treatment primarily to ibuprofen or acetaminophen; rizatriptan is FDA-approved for ages ≥6 years but evidence is mixed 1, 4, 3
• Adolescents ≥12 years: Full range of triptan options available, with intranasal formulations and combination NSAID-triptan therapy preferred for moderate-severe attacks 1, 2
• Younger children requiring prevention: Cyproheptadine may be considered for those unable to swallow tablets, though evidence is limited 5